Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
1401
1402
1403
1404
1405
1406
1407
1408
1409
1410
1411
1412
1413
1414
1415
1416
1417
1418
1419
1420
1421
1422
1423
1424
1425
1426
1427
1428
1429
1430
1431
1432
1433
1434
1435
1436
1437
1438
1439
1440
1441
1442
1443
1444
1445
1446
1447
1448
1449
1450
1451
1452
1453
1454
1455
1456
1457
1458
1459
1460
1461
1462
1463
1464
1465
1466
1467
1468
1469
1470
1471
1472
1473
1474
1475
1476
1477
1478
1479
1480
1481
1482
1483
1484
1485
1486
1487
1488
1489
1490
1491
1492
1493
1494
1495
1496
1497
1498
1499
1500
1501
1502
1503
1504
1505
1506
1507
1508
1509
1510
1511
1512
1513
1514
1515
1516
1517
1518
1519
1520
1521
1522
1523
1524
1525
1526
1527
1528
1529
1530
1531
1532
1533
1534
1535
1536
1537
1538
1539
1540
1541
1542
1543
1544
1545
1546
1547
1548
1549
1550
1551
1552
1553
1554
1555
1556
1557
1558
1559
1560
1561
1562
1563
1564
1565
1566
1567
1568
1569
1570
1571
1572
1573
1574
1575
1576
1577
1578
1579
1580
1581
1582
1583
1584
1585
1586
1587
1588
1589
1590
1591
1592
1593
1594
1595
1596
1597
1598
1599
1600
| UnnamedSample_HQ_transcript/39724|m.11792 | UnnamedSample_HQ_transcript/39724 | Coverage 0.913 too low. | 55b43bc26a7cd9243d7b4cc8015152a8 | 779 | Pfam | PF10551 | MULE transposase domain | 306 | 399 | 4.4E-11 | T | 22-09-2020 | IPR018289 | MULE transposase domain |
| UnnamedSample_HQ_transcript/60245|m.16108 | UnnamedSample_HQ_transcript/60245 | Coverage 0.977 too low. | 07526b3efcff3fe0123c632f65964efc | 454 | Pfam | PF00651 | BTB/POZ domain | 281 | 385 | 1.6E-23 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/103607|m.23059 | UnnamedSample_HQ_transcript/103607 | Coverage 0.852 too low. | 5852a78435c1023f829677044cccb03c | 326 | Pfam | PF00704 | Glycosyl hydrolases family 18 | 26 | 308 | 1.6E-46 | T | 22-09-2020 | IPR001223 | Glycoside hydrolase family 18, catalytic domain |
| UnnamedSample_HQ_transcript/59743|m.16008 | UnnamedSample_HQ_transcript/59743 | Coverage 0.057 too low. | 74292f67d99ed2ff807150eaeff45d6e | 245 | Pfam | PF00261 | Tropomyosin | 9 | 243 | 2.7E-81 | T | 22-09-2020 | IPR000533 | Tropomyosin |
| UnnamedSample_HQ_transcript/59263|m.15903 | UnnamedSample_HQ_transcript/59263 | Coverage 0.945 too low. | 6ccc8f4e5cdba5a70badd849e51db97c | 641 | Pfam | PF00435 | Spectrin repeat | 178 | 267 | 3.6E-6 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/59263|m.15903 | UnnamedSample_HQ_transcript/59263 | Coverage 0.945 too low. | 6ccc8f4e5cdba5a70badd849e51db97c | 641 | Pfam | PF00435 | Spectrin repeat | 279 | 382 | 4.5E-6 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/59212|m.15890 | UnnamedSample_HQ_transcript/59212 | Coverage 0.982 too low. | 6d41fbe72632d335ce318f68983c60f7 | 454 | Pfam | PF00083 | Sugar (and other) transporter | 19 | 449 | 5.7E-48 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/115039|m.24402 | UnnamedSample_HQ_transcript/115039 | Coverage 0.989 too low. | f0cb10dbd6680979bf671a2b0a34b365 | 225 | Pfam | PF07147 | Mitochondrial 28S ribosomal protein S30 (PDCD9) | 103 | 224 | 1.6E-10 | T | 22-09-2020 | IPR010793 | Ribosomal protein L37/S30 |
| UnnamedSample_HQ_transcript/47695|m.13507 | UnnamedSample_HQ_transcript/47695 | Identity 0.852 too low. | bdda903b80e2005538c17f4ad41259f1 | 374 | Pfam | PF00017 | SH2 domain | 186 | 264 | 5.2E-10 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/47695|m.13507 | UnnamedSample_HQ_transcript/47695 | Identity 0.852 too low. | bdda903b80e2005538c17f4ad41259f1 | 374 | Pfam | PF02864 | STAT protein, DNA binding domain | 1 | 66 | 4.7E-19 | T | 22-09-2020 | IPR013801 | STAT transcription factor, DNA-binding |
| UnnamedSample_HQ_transcript/103934|m.23103 | UnnamedSample_HQ_transcript/103934 | Coverage 0.630 too low. | b78ca28d8423151735af86d38701dd0e | 165 | Pfam | PF00110 | wnt family | 2 | 162 | 6.8E-62 | T | 22-09-2020 | IPR005817 | Wnt |
| UnnamedSample_HQ_transcript/77507|m.19290 | UnnamedSample_HQ_transcript/77507 | Coverage 0.863 too low. | c1c3d4d01b9e68d240c79a1a1c7aa9ea | 463 | Pfam | PF00501 | AMP-binding enzyme | 74 | 427 | 1.4E-56 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/31974|m.9943 | UnnamedSample_HQ_transcript/31974 | Coverage 0.919 too low. | 82bd8fadcac8e595cc3f7e906734abcf | 660 | Pfam | PF01457 | Leishmanolysin | 140 | 610 | 6.1E-70 | T | 22-09-2020 | IPR001577 | Peptidase M8, leishmanolysin |
| UnnamedSample_HQ_transcript/32361|m.10043 | UnnamedSample_HQ_transcript/32361 | Coverage 0.919 too low. | 82bd8fadcac8e595cc3f7e906734abcf | 660 | Pfam | PF01457 | Leishmanolysin | 140 | 610 | 6.1E-70 | T | 22-09-2020 | IPR001577 | Peptidase M8, leishmanolysin |
| UnnamedSample_HQ_transcript/26698|m.8651 | UnnamedSample_HQ_transcript/26698 | Coverage 0.963 too low. | f0b6da7a62ce2ff905c5befa58d218c7 | 874 | Pfam | PF00010 | Helix-loop-helix DNA-binding domain | 671 | 725 | 9.6E-12 | T | 22-09-2020 | IPR011598 | Myc-type, basic helix-loop-helix (bHLH) domain |
| UnnamedSample_HQ_transcript/16209|m.5772 | UnnamedSample_HQ_transcript/16209 | Coverage 0.917 too low. | 4368d2a4454db6e2d2c6fd8f141067e2 | 1042 | Pfam | PF00567 | Tudor domain | 74 | 154 | 7.5E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/16209|m.5772 | UnnamedSample_HQ_transcript/16209 | Coverage 0.917 too low. | 4368d2a4454db6e2d2c6fd8f141067e2 | 1042 | Pfam | PF00567 | Tudor domain | 663 | 781 | 3.0E-7 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/16209|m.5772 | UnnamedSample_HQ_transcript/16209 | Coverage 0.917 too low. | 4368d2a4454db6e2d2c6fd8f141067e2 | 1042 | Pfam | PF00567 | Tudor domain | 202 | 305 | 2.3E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/16209|m.5772 | UnnamedSample_HQ_transcript/16209 | Coverage 0.917 too low. | 4368d2a4454db6e2d2c6fd8f141067e2 | 1042 | Pfam | PF00567 | Tudor domain | 904 | 988 | 1.3E-9 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/13898|m.5080 | UnnamedSample_HQ_transcript/13898 | Coverage 0.988 too low. | d9581d39131e3d2d62dec7eadb0df634 | 442 | Pfam | PF02826 | D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain | 134 | 318 | 2.9E-55 | T | 22-09-2020 | IPR006140 | D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain |
| UnnamedSample_HQ_transcript/13898|m.5080 | UnnamedSample_HQ_transcript/13898 | Coverage 0.988 too low. | d9581d39131e3d2d62dec7eadb0df634 | 442 | Pfam | PF00389 | D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain | 39 | 353 | 3.9E-28 | T | 22-09-2020 | IPR006139 | D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain |
| UnnamedSample_HQ_transcript/42462|m.12362 | UnnamedSample_HQ_transcript/42462 | Coverage 0.462 too low. | 8859dec311c31bde52fdef8d7265aa1b | 277 | Pfam | PF00261 | Tropomyosin | 175 | 268 | 1.8E-33 | T | 22-09-2020 | IPR000533 | Tropomyosin |
| UnnamedSample_HQ_transcript/86120|m.20672 | UnnamedSample_HQ_transcript/86120 | Coverage 0.569 too low. | ba833ab809e07a73b4be703a646baef2 | 192 | Pfam | PF07776 | Zinc-finger associated domain (zf-AD) | 25 | 99 | 2.9E-11 | T | 22-09-2020 | IPR012934 | Zinc finger, AD-type |
| UnnamedSample_HQ_transcript/105167|m.23250 | UnnamedSample_HQ_transcript/105167 | Coverage 0.466 too low. | 46e065aa9b9950a83652e74277c7b710 | 106 | Pfam | PF00903 | Glyoxalase/Bleomycin resistance protein/Dioxygenase superfamily | 30 | 102 | 9.9E-7 | T | 22-09-2020 | IPR004360 | Glyoxalase/fosfomycin resistance/dioxygenase domain |
| UnnamedSample_HQ_transcript/41991|m.12259 | UnnamedSample_HQ_transcript/41991 | Coverage 0.741 too low. | 332b2388388d756a4deb142480cad8f6 | 487 | Pfam | PF00069 | Protein kinase domain | 14 | 272 | 5.7E-76 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/41991|m.12259 | UnnamedSample_HQ_transcript/41991 | Coverage 0.741 too low. | 332b2388388d756a4deb142480cad8f6 | 487 | Pfam | PF08332 | Calcium/calmodulin dependent protein kinase II association domain | 348 | 472 | 6.8E-57 | T | 22-09-2020 | IPR013543 | Calcium/calmodulin-dependent protein kinase II, association-domain |
| UnnamedSample_HQ_transcript/18975|m.6572 | UnnamedSample_HQ_transcript/18975 | Coverage 0.053 too low. | 9885406d4f401f5678c6e6651cb01081 | 1017 | Pfam | PF01074 | Glycosyl hydrolases family 38 N-terminal domain | 88 | 412 | 5.4E-99 | T | 22-09-2020 | IPR000602 | Glycoside hydrolase family 38, N-terminal domain |
| UnnamedSample_HQ_transcript/18975|m.6572 | UnnamedSample_HQ_transcript/18975 | Coverage 0.053 too low. | 9885406d4f401f5678c6e6651cb01081 | 1017 | Pfam | PF09261 | Alpha mannosidase middle domain | 418 | 522 | 5.0E-24 | T | 22-09-2020 | IPR015341 | Glycoside hydrolase family 38, central domain |
| UnnamedSample_HQ_transcript/18975|m.6572 | UnnamedSample_HQ_transcript/18975 | Coverage 0.053 too low. | 9885406d4f401f5678c6e6651cb01081 | 1017 | Pfam | PF07748 | Glycosyl hydrolases family 38 C-terminal domain | 684 | 886 | 1.6E-29 | T | 22-09-2020 | IPR011682 | Glycosyl hydrolase family 38, C-terminal |
| UnnamedSample_HQ_transcript/18251|m.6380 | UnnamedSample_HQ_transcript/18251 | Coverage 0.383 too low. | bde2f3300a6236434860ae49fd646f1b | 834 | Pfam | PF03160 | Calx-beta domain | 464 | 561 | 7.2E-22 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/18251|m.6380 | UnnamedSample_HQ_transcript/18251 | Coverage 0.383 too low. | bde2f3300a6236434860ae49fd646f1b | 834 | Pfam | PF03160 | Calx-beta domain | 354 | 446 | 1.2E-21 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/18251|m.6380 | UnnamedSample_HQ_transcript/18251 | Coverage 0.383 too low. | bde2f3300a6236434860ae49fd646f1b | 834 | Pfam | PF01699 | Sodium/calcium exchanger protein | 659 | 823 | 2.6E-17 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/18251|m.6380 | UnnamedSample_HQ_transcript/18251 | Coverage 0.383 too low. | bde2f3300a6236434860ae49fd646f1b | 834 | Pfam | PF01699 | Sodium/calcium exchanger protein | 41 | 225 | 2.4E-24 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/19130|m.6618 | UnnamedSample_HQ_transcript/19130 | Coverage 0.314 too low. | bde2f3300a6236434860ae49fd646f1b | 834 | Pfam | PF03160 | Calx-beta domain | 464 | 561 | 7.2E-22 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/19130|m.6618 | UnnamedSample_HQ_transcript/19130 | Coverage 0.314 too low. | bde2f3300a6236434860ae49fd646f1b | 834 | Pfam | PF03160 | Calx-beta domain | 354 | 446 | 1.2E-21 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/19130|m.6618 | UnnamedSample_HQ_transcript/19130 | Coverage 0.314 too low. | bde2f3300a6236434860ae49fd646f1b | 834 | Pfam | PF01699 | Sodium/calcium exchanger protein | 659 | 823 | 2.6E-17 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/19130|m.6618 | UnnamedSample_HQ_transcript/19130 | Coverage 0.314 too low. | bde2f3300a6236434860ae49fd646f1b | 834 | Pfam | PF01699 | Sodium/calcium exchanger protein | 41 | 225 | 2.4E-24 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/27064|m.8731 | UnnamedSample_HQ_transcript/27064 | Coverage 0.164 too low. | bde2f3300a6236434860ae49fd646f1b | 834 | Pfam | PF03160 | Calx-beta domain | 464 | 561 | 7.2E-22 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/27064|m.8731 | UnnamedSample_HQ_transcript/27064 | Coverage 0.164 too low. | bde2f3300a6236434860ae49fd646f1b | 834 | Pfam | PF03160 | Calx-beta domain | 354 | 446 | 1.2E-21 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/27064|m.8731 | UnnamedSample_HQ_transcript/27064 | Coverage 0.164 too low. | bde2f3300a6236434860ae49fd646f1b | 834 | Pfam | PF01699 | Sodium/calcium exchanger protein | 659 | 823 | 2.6E-17 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/27064|m.8731 | UnnamedSample_HQ_transcript/27064 | Coverage 0.164 too low. | bde2f3300a6236434860ae49fd646f1b | 834 | Pfam | PF01699 | Sodium/calcium exchanger protein | 41 | 225 | 2.4E-24 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/17494|m.6156 | UnnamedSample_HQ_transcript/17494 | Coverage 0.301 too low. | bde2f3300a6236434860ae49fd646f1b | 834 | Pfam | PF03160 | Calx-beta domain | 464 | 561 | 7.2E-22 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/17494|m.6156 | UnnamedSample_HQ_transcript/17494 | Coverage 0.301 too low. | bde2f3300a6236434860ae49fd646f1b | 834 | Pfam | PF03160 | Calx-beta domain | 354 | 446 | 1.2E-21 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/17494|m.6156 | UnnamedSample_HQ_transcript/17494 | Coverage 0.301 too low. | bde2f3300a6236434860ae49fd646f1b | 834 | Pfam | PF01699 | Sodium/calcium exchanger protein | 659 | 823 | 2.6E-17 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/17494|m.6156 | UnnamedSample_HQ_transcript/17494 | Coverage 0.301 too low. | bde2f3300a6236434860ae49fd646f1b | 834 | Pfam | PF01699 | Sodium/calcium exchanger protein | 41 | 225 | 2.4E-24 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/16962|m.5994 | UnnamedSample_HQ_transcript/16962 | Coverage 0.886 too low. | f84d16451b5f3a1d835e5e2d46c23e85 | 1085 | Pfam | PF16898 | C-terminal associated domain of TOPRIM | 573 | 716 | 7.3E-48 | T | 22-09-2020 | IPR031660 | C-terminal associated domain of TOPRIM |
| UnnamedSample_HQ_transcript/16962|m.5994 | UnnamedSample_HQ_transcript/16962 | Coverage 0.886 too low. | f84d16451b5f3a1d835e5e2d46c23e85 | 1085 | Pfam | PF00204 | DNA gyrase B | 268 | 428 | 5.2E-26 | T | 22-09-2020 | IPR013506 | DNA topoisomerase, type IIA, subunit B, domain 2 |
| UnnamedSample_HQ_transcript/16962|m.5994 | UnnamedSample_HQ_transcript/16962 | Coverage 0.886 too low. | f84d16451b5f3a1d835e5e2d46c23e85 | 1085 | Pfam | PF00521 | DNA gyrase/topoisomerase IV, subunit A | 718 | 1080 | 4.7E-113 | T | 22-09-2020 | IPR002205 | DNA topoisomerase, type IIA, subunit A/C-terminal |
| UnnamedSample_HQ_transcript/16962|m.5994 | UnnamedSample_HQ_transcript/16962 | Coverage 0.886 too low. | f84d16451b5f3a1d835e5e2d46c23e85 | 1085 | Pfam | PF02518 | Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase | 81 | 225 | 1.1E-15 | T | 22-09-2020 | IPR003594 | Histidine kinase/HSP90-like ATPase |
| UnnamedSample_HQ_transcript/16962|m.5994 | UnnamedSample_HQ_transcript/16962 | Coverage 0.886 too low. | f84d16451b5f3a1d835e5e2d46c23e85 | 1085 | Pfam | PF01751 | Toprim domain | 457 | 558 | 5.7E-8 | T | 22-09-2020 | IPR006171 | TOPRIM domain |
| UnnamedSample_HQ_transcript/3480|m.1611 | UnnamedSample_HQ_transcript/3480 | Unmapped. | f8118355c3ab44e50351b37fadfe671d | 968 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 491 | 860 | 1.0E-9 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/16297|m.5793 | UnnamedSample_HQ_transcript/16297 | Unmapped. | f8118355c3ab44e50351b37fadfe671d | 968 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 491 | 860 | 1.0E-9 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/3554|m.1637 | UnnamedSample_HQ_transcript/3554 | Unmapped. | f8118355c3ab44e50351b37fadfe671d | 968 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 491 | 860 | 1.0E-9 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/6525|m.2716 | UnnamedSample_HQ_transcript/6525 | Identity 0.897 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00052 | Laminin B (Domain IV) | 556 | 687 | 1.2E-26 | T | 22-09-2020 | IPR000034 | Laminin IV |
| UnnamedSample_HQ_transcript/6525|m.2716 | UnnamedSample_HQ_transcript/6525 | Identity 0.897 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00053 | Laminin EGF domain | 393 | 437 | 2.7E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/6525|m.2716 | UnnamedSample_HQ_transcript/6525 | Identity 0.897 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00053 | Laminin EGF domain | 440 | 490 | 6.3E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/6525|m.2716 | UnnamedSample_HQ_transcript/6525 | Identity 0.897 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00053 | Laminin EGF domain | 337 | 384 | 1.9E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/6525|m.2716 | UnnamedSample_HQ_transcript/6525 | Identity 0.897 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00053 | Laminin EGF domain | 772 | 817 | 4.7E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/6525|m.2716 | UnnamedSample_HQ_transcript/6525 | Identity 0.897 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00053 | Laminin EGF domain | 723 | 769 | 3.8E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/6525|m.2716 | UnnamedSample_HQ_transcript/6525 | Identity 0.897 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00053 | Laminin EGF domain | 688 | 708 | 0.012 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/6525|m.2716 | UnnamedSample_HQ_transcript/6525 | Identity 0.897 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00053 | Laminin EGF domain | 276 | 324 | 8.3E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/6525|m.2716 | UnnamedSample_HQ_transcript/6525 | Identity 0.897 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00053 | Laminin EGF domain | 882 | 933 | 8.9E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/6525|m.2716 | UnnamedSample_HQ_transcript/6525 | Identity 0.897 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00053 | Laminin EGF domain | 984 | 1027 | 6.5E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/6525|m.2716 | UnnamedSample_HQ_transcript/6525 | Identity 0.897 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00053 | Laminin EGF domain | 827 | 875 | 6.1E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/6525|m.2716 | UnnamedSample_HQ_transcript/6525 | Identity 0.897 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00053 | Laminin EGF domain | 936 | 981 | 1.7E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/6525|m.2716 | UnnamedSample_HQ_transcript/6525 | Identity 0.897 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00055 | Laminin N-terminal (Domain VI) | 41 | 273 | 1.1E-68 | T | 22-09-2020 | IPR008211 | Laminin, N-terminal |
| UnnamedSample_HQ_transcript/5847|m.2480 | UnnamedSample_HQ_transcript/5847 | Identity 0.900 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00052 | Laminin B (Domain IV) | 556 | 687 | 1.2E-26 | T | 22-09-2020 | IPR000034 | Laminin IV |
| UnnamedSample_HQ_transcript/5847|m.2480 | UnnamedSample_HQ_transcript/5847 | Identity 0.900 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00053 | Laminin EGF domain | 393 | 437 | 2.7E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/5847|m.2480 | UnnamedSample_HQ_transcript/5847 | Identity 0.900 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00053 | Laminin EGF domain | 440 | 490 | 6.3E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/5847|m.2480 | UnnamedSample_HQ_transcript/5847 | Identity 0.900 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00053 | Laminin EGF domain | 337 | 384 | 1.9E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/5847|m.2480 | UnnamedSample_HQ_transcript/5847 | Identity 0.900 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00053 | Laminin EGF domain | 772 | 817 | 4.7E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/5847|m.2480 | UnnamedSample_HQ_transcript/5847 | Identity 0.900 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00053 | Laminin EGF domain | 723 | 769 | 3.8E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/5847|m.2480 | UnnamedSample_HQ_transcript/5847 | Identity 0.900 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00053 | Laminin EGF domain | 688 | 708 | 0.012 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/5847|m.2480 | UnnamedSample_HQ_transcript/5847 | Identity 0.900 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00053 | Laminin EGF domain | 276 | 324 | 8.3E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/5847|m.2480 | UnnamedSample_HQ_transcript/5847 | Identity 0.900 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00053 | Laminin EGF domain | 882 | 933 | 8.9E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/5847|m.2480 | UnnamedSample_HQ_transcript/5847 | Identity 0.900 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00053 | Laminin EGF domain | 984 | 1027 | 6.5E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/5847|m.2480 | UnnamedSample_HQ_transcript/5847 | Identity 0.900 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00053 | Laminin EGF domain | 827 | 875 | 6.1E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/5847|m.2480 | UnnamedSample_HQ_transcript/5847 | Identity 0.900 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00053 | Laminin EGF domain | 936 | 981 | 1.7E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/5847|m.2480 | UnnamedSample_HQ_transcript/5847 | Identity 0.900 too low. | f65405eb2c82c5ec8ba1ec21ea46e4a6 | 1413 | Pfam | PF00055 | Laminin N-terminal (Domain VI) | 41 | 273 | 1.1E-68 | T | 22-09-2020 | IPR008211 | Laminin, N-terminal |
| UnnamedSample_HQ_transcript/57883|m.15628 | UnnamedSample_HQ_transcript/57883 | Identity 0.594 too low. | 371cc7276b6b2f4c48033f8c49b36782 | 435 | Pfam | PF13639 | Ring finger domain | 243 | 286 | 2.8E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/57883|m.15628 | UnnamedSample_HQ_transcript/57883 | Identity 0.594 too low. | 371cc7276b6b2f4c48033f8c49b36782 | 435 | Pfam | PF02225 | PA domain | 65 | 158 | 1.7E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/64850|m.17008 | UnnamedSample_HQ_transcript/64850 | Identity 0.560 too low. | 371cc7276b6b2f4c48033f8c49b36782 | 435 | Pfam | PF13639 | Ring finger domain | 243 | 286 | 2.8E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/64850|m.17008 | UnnamedSample_HQ_transcript/64850 | Identity 0.560 too low. | 371cc7276b6b2f4c48033f8c49b36782 | 435 | Pfam | PF02225 | PA domain | 65 | 158 | 1.7E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/63327|m.16695 | UnnamedSample_HQ_transcript/63327 | Coverage 0.561 too low. | 371cc7276b6b2f4c48033f8c49b36782 | 435 | Pfam | PF13639 | Ring finger domain | 243 | 286 | 2.8E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/63327|m.16695 | UnnamedSample_HQ_transcript/63327 | Coverage 0.561 too low. | 371cc7276b6b2f4c48033f8c49b36782 | 435 | Pfam | PF02225 | PA domain | 65 | 158 | 1.7E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/99228|m.22524 | UnnamedSample_HQ_transcript/99228 | Coverage 0.347 too low. | 8354c2fd958d24cb4cf0471346846880 | 365 | Pfam | PF00130 | Phorbol esters/diacylglycerol binding domain (C1 domain) | 41 | 91 | 1.6E-18 | T | 22-09-2020 | IPR002219 | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain |
| UnnamedSample_HQ_transcript/99228|m.22524 | UnnamedSample_HQ_transcript/99228 | Coverage 0.347 too low. | 8354c2fd958d24cb4cf0471346846880 | 365 | Pfam | PF00130 | Phorbol esters/diacylglycerol binding domain (C1 domain) | 106 | 158 | 4.0E-16 | T | 22-09-2020 | IPR002219 | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain |
| UnnamedSample_HQ_transcript/99228|m.22524 | UnnamedSample_HQ_transcript/99228 | Coverage 0.347 too low. | 8354c2fd958d24cb4cf0471346846880 | 365 | Pfam | PF00168 | C2 domain | 176 | 280 | 1.5E-27 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/28548|m.9101 | UnnamedSample_HQ_transcript/28548 | Coverage 0.169 too low. | 2b77168704e343fab065b0265943dd0f | 505 | Pfam | PF00505 | HMG (high mobility group) box | 271 | 338 | 2.0E-15 | T | 22-09-2020 | IPR009071 | High mobility group box domain |
| UnnamedSample_HQ_transcript/20658|m.7054 | UnnamedSample_HQ_transcript/20658 | Coverage 0.052 too low. | abc86372d591e3f84c8ef552604a4225 | 1043 | Pfam | PF09261 | Alpha mannosidase middle domain | 418 | 522 | 5.1E-24 | T | 22-09-2020 | IPR015341 | Glycoside hydrolase family 38, central domain |
| UnnamedSample_HQ_transcript/20658|m.7054 | UnnamedSample_HQ_transcript/20658 | Coverage 0.052 too low. | abc86372d591e3f84c8ef552604a4225 | 1043 | Pfam | PF01074 | Glycosyl hydrolases family 38 N-terminal domain | 88 | 412 | 9.9E-99 | T | 22-09-2020 | IPR000602 | Glycoside hydrolase family 38, N-terminal domain |
| UnnamedSample_HQ_transcript/20658|m.7054 | UnnamedSample_HQ_transcript/20658 | Coverage 0.052 too low. | abc86372d591e3f84c8ef552604a4225 | 1043 | Pfam | PF07748 | Glycosyl hydrolases family 38 C-terminal domain | 684 | 886 | 1.7E-29 | T | 22-09-2020 | IPR011682 | Glycosyl hydrolase family 38, C-terminal |
| UnnamedSample_HQ_transcript/69313|m.17811 | UnnamedSample_HQ_transcript/69313 | Identity 0.603 too low. | 2c023a32943b42e421fbb6f86f8a0dd3 | 281 | Pfam | PF09457 | FIP domain | 237 | 277 | 6.3E-12 | T | 22-09-2020 | IPR019018 | Rab-binding domain FIP-RBD |
| UnnamedSample_HQ_transcript/51758|m.14399 | UnnamedSample_HQ_transcript/51758 | Identity 0.674 too low. | 2c023a32943b42e421fbb6f86f8a0dd3 | 281 | Pfam | PF09457 | FIP domain | 237 | 277 | 6.3E-12 | T | 22-09-2020 | IPR019018 | Rab-binding domain FIP-RBD |
| UnnamedSample_HQ_transcript/64696|m.16979 | UnnamedSample_HQ_transcript/64696 | Coverage 0.178 too low. | 2c023a32943b42e421fbb6f86f8a0dd3 | 281 | Pfam | PF09457 | FIP domain | 237 | 277 | 6.3E-12 | T | 22-09-2020 | IPR019018 | Rab-binding domain FIP-RBD |
| UnnamedSample_HQ_transcript/96079|m.22103 | UnnamedSample_HQ_transcript/96079 | Coverage 0.825 too low. | 2b8ca1d39f10193cf25b1f6177aba021 | 312 | Pfam | PF06990 | Galactose-3-O-sulfotransferase | 63 | 311 | 1.9E-41 | T | 22-09-2020 | IPR009729 | Galactose-3-O-sulfotransferase |
| UnnamedSample_HQ_transcript/47093|m.13390 | UnnamedSample_HQ_transcript/47093 | Coverage 0.903 too low. | e4480183963339ed284305b0ab6372dc | 641 | Pfam | PF06325 | Ribosomal protein L11 methyltransferase (PrmA) | 161 | 234 | 4.1E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/28184|m.9012 | UnnamedSample_HQ_transcript/28184 | Identity 0.944 too low. | e4480183963339ed284305b0ab6372dc | 641 | Pfam | PF06325 | Ribosomal protein L11 methyltransferase (PrmA) | 161 | 234 | 4.1E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/4213|m.1882 | UnnamedSample_HQ_transcript/4213 | Coverage 0.761 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1022 | 1125 | 2.8E-37 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/4213|m.1882 | UnnamedSample_HQ_transcript/4213 | Coverage 0.761 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1130 | 1240 | 2.7E-43 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/4213|m.1882 | UnnamedSample_HQ_transcript/4213 | Coverage 0.761 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 113 | 170 | 2.1E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4213|m.1882 | UnnamedSample_HQ_transcript/4213 | Coverage 0.761 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 467 | 523 | 1.3E-6 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4213|m.1882 | UnnamedSample_HQ_transcript/4213 | Coverage 0.761 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 367 | 415 | 3.1E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4213|m.1882 | UnnamedSample_HQ_transcript/4213 | Coverage 0.761 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 263 | 313 | 4.2E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4213|m.1882 | UnnamedSample_HQ_transcript/4213 | Coverage 0.761 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 149 | 209 | 4.3E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4213|m.1882 | UnnamedSample_HQ_transcript/4213 | Coverage 0.761 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 564 | 619 | 2.2E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4213|m.1882 | UnnamedSample_HQ_transcript/4213 | Coverage 0.761 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 38 | 89 | 1.6E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4213|m.1882 | UnnamedSample_HQ_transcript/4213 | Coverage 0.761 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 903 | 961 | 9.9E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4213|m.1882 | UnnamedSample_HQ_transcript/4213 | Coverage 0.761 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 856 | 912 | 1.1E-6 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4213|m.1882 | UnnamedSample_HQ_transcript/4213 | Coverage 0.761 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 951 | 1009 | 1.4E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4213|m.1882 | UnnamedSample_HQ_transcript/4213 | Coverage 0.761 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 220 | 272 | 1.1E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4213|m.1882 | UnnamedSample_HQ_transcript/4213 | Coverage 0.761 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 125 | 180 | 2.0E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4213|m.1882 | UnnamedSample_HQ_transcript/4213 | Coverage 0.761 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 629 | 683 | 2.0E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4213|m.1882 | UnnamedSample_HQ_transcript/4213 | Coverage 0.761 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 50 | 107 | 2.8E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4213|m.1882 | UnnamedSample_HQ_transcript/4213 | Coverage 0.761 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 318 | 374 | 1.6E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/4213|m.1882 | UnnamedSample_HQ_transcript/4213 | Coverage 0.761 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 403 | 458 | 8.4E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/3824|m.1746 | UnnamedSample_HQ_transcript/3824 | Coverage 0.766 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1022 | 1125 | 2.8E-37 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/3824|m.1746 | UnnamedSample_HQ_transcript/3824 | Coverage 0.766 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1130 | 1240 | 2.7E-43 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/3824|m.1746 | UnnamedSample_HQ_transcript/3824 | Coverage 0.766 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 113 | 170 | 2.1E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/3824|m.1746 | UnnamedSample_HQ_transcript/3824 | Coverage 0.766 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 467 | 523 | 1.3E-6 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/3824|m.1746 | UnnamedSample_HQ_transcript/3824 | Coverage 0.766 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 367 | 415 | 3.1E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/3824|m.1746 | UnnamedSample_HQ_transcript/3824 | Coverage 0.766 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 263 | 313 | 4.2E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/3824|m.1746 | UnnamedSample_HQ_transcript/3824 | Coverage 0.766 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 149 | 209 | 4.3E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/3824|m.1746 | UnnamedSample_HQ_transcript/3824 | Coverage 0.766 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 564 | 619 | 2.2E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/3824|m.1746 | UnnamedSample_HQ_transcript/3824 | Coverage 0.766 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 38 | 89 | 1.6E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/3824|m.1746 | UnnamedSample_HQ_transcript/3824 | Coverage 0.766 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 903 | 961 | 9.9E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/3824|m.1746 | UnnamedSample_HQ_transcript/3824 | Coverage 0.766 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 856 | 912 | 1.1E-6 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/3824|m.1746 | UnnamedSample_HQ_transcript/3824 | Coverage 0.766 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 951 | 1009 | 1.4E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/3824|m.1746 | UnnamedSample_HQ_transcript/3824 | Coverage 0.766 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 220 | 272 | 1.1E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/3824|m.1746 | UnnamedSample_HQ_transcript/3824 | Coverage 0.766 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 125 | 180 | 2.0E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/3824|m.1746 | UnnamedSample_HQ_transcript/3824 | Coverage 0.766 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 629 | 683 | 2.0E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/3824|m.1746 | UnnamedSample_HQ_transcript/3824 | Coverage 0.766 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 50 | 107 | 2.8E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/3824|m.1746 | UnnamedSample_HQ_transcript/3824 | Coverage 0.766 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 318 | 374 | 1.6E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/3824|m.1746 | UnnamedSample_HQ_transcript/3824 | Coverage 0.766 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 403 | 458 | 8.4E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5520|m.2367 | UnnamedSample_HQ_transcript/5520 | Coverage 0.747 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1022 | 1125 | 2.8E-37 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/5520|m.2367 | UnnamedSample_HQ_transcript/5520 | Coverage 0.747 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1130 | 1240 | 2.7E-43 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/5520|m.2367 | UnnamedSample_HQ_transcript/5520 | Coverage 0.747 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 113 | 170 | 2.1E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5520|m.2367 | UnnamedSample_HQ_transcript/5520 | Coverage 0.747 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 467 | 523 | 1.3E-6 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5520|m.2367 | UnnamedSample_HQ_transcript/5520 | Coverage 0.747 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 367 | 415 | 3.1E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5520|m.2367 | UnnamedSample_HQ_transcript/5520 | Coverage 0.747 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 263 | 313 | 4.2E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5520|m.2367 | UnnamedSample_HQ_transcript/5520 | Coverage 0.747 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 149 | 209 | 4.3E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5520|m.2367 | UnnamedSample_HQ_transcript/5520 | Coverage 0.747 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 564 | 619 | 2.2E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5520|m.2367 | UnnamedSample_HQ_transcript/5520 | Coverage 0.747 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 38 | 89 | 1.6E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5520|m.2367 | UnnamedSample_HQ_transcript/5520 | Coverage 0.747 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 903 | 961 | 9.9E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5520|m.2367 | UnnamedSample_HQ_transcript/5520 | Coverage 0.747 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 856 | 912 | 1.1E-6 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5520|m.2367 | UnnamedSample_HQ_transcript/5520 | Coverage 0.747 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 951 | 1009 | 1.4E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5520|m.2367 | UnnamedSample_HQ_transcript/5520 | Coverage 0.747 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 220 | 272 | 1.1E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5520|m.2367 | UnnamedSample_HQ_transcript/5520 | Coverage 0.747 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 125 | 180 | 2.0E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5520|m.2367 | UnnamedSample_HQ_transcript/5520 | Coverage 0.747 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 629 | 683 | 2.0E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5520|m.2367 | UnnamedSample_HQ_transcript/5520 | Coverage 0.747 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 50 | 107 | 2.8E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5520|m.2367 | UnnamedSample_HQ_transcript/5520 | Coverage 0.747 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 318 | 374 | 1.6E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/5520|m.2367 | UnnamedSample_HQ_transcript/5520 | Coverage 0.747 too low. | 7d801fdb51fa1c80ba5ca3f937040f14 | 1242 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 403 | 458 | 8.4E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/25824|m.8427 | UnnamedSample_HQ_transcript/25824 | Identity 0.777 too low. | 8583e49915c01274d23e774a492d27ac | 594 | Pfam | PF17047 | Synaptotagmin-like mitochondrial-lipid-binding domain | 98 | 275 | 3.9E-40 | T | 22-09-2020 | IPR039010 | Synaptotagmin, SMP domain |
| UnnamedSample_HQ_transcript/25824|m.8427 | UnnamedSample_HQ_transcript/25824 | Identity 0.777 too low. | 8583e49915c01274d23e774a492d27ac | 594 | Pfam | PF00168 | C2 domain | 292 | 398 | 3.4E-19 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/25824|m.8427 | UnnamedSample_HQ_transcript/25824 | Identity 0.777 too low. | 8583e49915c01274d23e774a492d27ac | 594 | Pfam | PF00168 | C2 domain | 442 | 533 | 1.4E-8 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/45174|m.12947 | UnnamedSample_HQ_transcript/45174 | Identity 0.778 too low. | 115079d23a5bfab07aea969d12b7f666 | 474 | Pfam | PF00149 | Calcineurin-like phosphoesterase | 2 | 212 | 1.4E-10 | T | 22-09-2020 | IPR004843 | Calcineurin-like phosphoesterase domain, ApaH type |
| UnnamedSample_HQ_transcript/48214|m.13625 | UnnamedSample_HQ_transcript/48214 | Coverage 0.293 too low. | a8689076fe6f0fd3b9d1fa7fd20c8a8c | 219 | Pfam | PF13927 | Immunoglobulin domain | 26 | 93 | 1.9E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/48214|m.13625 | UnnamedSample_HQ_transcript/48214 | Coverage 0.293 too low. | a8689076fe6f0fd3b9d1fa7fd20c8a8c | 219 | Pfam | PF08205 | CD80-like C2-set immunoglobulin domain | 120 | 192 | 1.8E-9 | T | 22-09-2020 | IPR013162 | CD80-like, immunoglobulin C2-set |
| UnnamedSample_HQ_transcript/59460|m.15941 | UnnamedSample_HQ_transcript/59460 | Coverage 0.160 too low. | 707c643b5b0de38abbebef3ea839c0d2 | 420 | Pfam | PF00651 | BTB/POZ domain | 28 | 121 | 7.8E-11 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/55753|m.15186 | UnnamedSample_HQ_transcript/55753 | Coverage 0.152 too low. | 707c643b5b0de38abbebef3ea839c0d2 | 420 | Pfam | PF00651 | BTB/POZ domain | 28 | 121 | 7.8E-11 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/3414|m.1596 | UnnamedSample_HQ_transcript/3414 | Identity 0.807 too low. | d2761d07a0f31de7a1115675f0d64ab4 | 1293 | Pfam | PF00266 | Aminotransferase class-V | 67 | 435 | 5.7E-26 | T | 22-09-2020 | IPR000192 | Aminotransferase class V domain |
| UnnamedSample_HQ_transcript/3414|m.1596 | UnnamedSample_HQ_transcript/3414 | Identity 0.807 too low. | d2761d07a0f31de7a1115675f0d64ab4 | 1293 | Pfam | PF01171 | PP-loop family | 1125 | 1256 | 5.3E-7 | T | 22-09-2020 | IPR011063 | tRNA(Ile)-lysidine/2-thiocytidine synthase, N-terminal |
| UnnamedSample_HQ_transcript/36449|m.11039 | UnnamedSample_HQ_transcript/36449 | Identity 0.898 too low. | cf15a543267834efdf016d26dff004b9 | 581 | Pfam | PF00096 | Zinc finger, C2H2 type | 513 | 535 | 3.8E-6 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/36449|m.11039 | UnnamedSample_HQ_transcript/36449 | Identity 0.898 too low. | cf15a543267834efdf016d26dff004b9 | 581 | Pfam | PF00096 | Zinc finger, C2H2 type | 541 | 564 | 0.0053 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/36449|m.11039 | UnnamedSample_HQ_transcript/36449 | Identity 0.898 too low. | cf15a543267834efdf016d26dff004b9 | 581 | Pfam | PF00096 | Zinc finger, C2H2 type | 360 | 381 | 0.0016 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/36449|m.11039 | UnnamedSample_HQ_transcript/36449 | Identity 0.898 too low. | cf15a543267834efdf016d26dff004b9 | 581 | Pfam | PF00096 | Zinc finger, C2H2 type | 153 | 175 | 0.0015 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/36449|m.11039 | UnnamedSample_HQ_transcript/36449 | Identity 0.898 too low. | cf15a543267834efdf016d26dff004b9 | 581 | Pfam | PF18694 | Transactive response DNA-binding protein N-terminal domain | 10 | 81 | 3.8E-20 | T | 22-09-2020 | IPR041105 | TAR DNA-binding protein 43, N-terminal |
| UnnamedSample_HQ_transcript/55259|m.15085 | UnnamedSample_HQ_transcript/55259 | Coverage 0.914 too low. | cf15a543267834efdf016d26dff004b9 | 581 | Pfam | PF00096 | Zinc finger, C2H2 type | 513 | 535 | 3.8E-6 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/55259|m.15085 | UnnamedSample_HQ_transcript/55259 | Coverage 0.914 too low. | cf15a543267834efdf016d26dff004b9 | 581 | Pfam | PF00096 | Zinc finger, C2H2 type | 541 | 564 | 0.0053 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/55259|m.15085 | UnnamedSample_HQ_transcript/55259 | Coverage 0.914 too low. | cf15a543267834efdf016d26dff004b9 | 581 | Pfam | PF00096 | Zinc finger, C2H2 type | 360 | 381 | 0.0016 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/55259|m.15085 | UnnamedSample_HQ_transcript/55259 | Coverage 0.914 too low. | cf15a543267834efdf016d26dff004b9 | 581 | Pfam | PF00096 | Zinc finger, C2H2 type | 153 | 175 | 0.0015 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/55259|m.15085 | UnnamedSample_HQ_transcript/55259 | Coverage 0.914 too low. | cf15a543267834efdf016d26dff004b9 | 581 | Pfam | PF18694 | Transactive response DNA-binding protein N-terminal domain | 10 | 81 | 3.8E-20 | T | 22-09-2020 | IPR041105 | TAR DNA-binding protein 43, N-terminal |
| UnnamedSample_HQ_transcript/39679|m.11781 | UnnamedSample_HQ_transcript/39679 | Identity 0.895 too low. | cf15a543267834efdf016d26dff004b9 | 581 | Pfam | PF00096 | Zinc finger, C2H2 type | 513 | 535 | 3.8E-6 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/39679|m.11781 | UnnamedSample_HQ_transcript/39679 | Identity 0.895 too low. | cf15a543267834efdf016d26dff004b9 | 581 | Pfam | PF00096 | Zinc finger, C2H2 type | 541 | 564 | 0.0053 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/39679|m.11781 | UnnamedSample_HQ_transcript/39679 | Identity 0.895 too low. | cf15a543267834efdf016d26dff004b9 | 581 | Pfam | PF00096 | Zinc finger, C2H2 type | 360 | 381 | 0.0016 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/39679|m.11781 | UnnamedSample_HQ_transcript/39679 | Identity 0.895 too low. | cf15a543267834efdf016d26dff004b9 | 581 | Pfam | PF00096 | Zinc finger, C2H2 type | 153 | 175 | 0.0015 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/39679|m.11781 | UnnamedSample_HQ_transcript/39679 | Identity 0.895 too low. | cf15a543267834efdf016d26dff004b9 | 581 | Pfam | PF18694 | Transactive response DNA-binding protein N-terminal domain | 10 | 81 | 3.8E-20 | T | 22-09-2020 | IPR041105 | TAR DNA-binding protein 43, N-terminal |
| UnnamedSample_HQ_transcript/16324|m.5805 | UnnamedSample_HQ_transcript/16324 | Identity 0.753 too low. | 92fde10cd091048148a2c352f62bdbd2 | 294 | Pfam | PF13855 | Leucine rich repeat | 92 | 149 | 2.6E-12 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/65213|m.17065 | UnnamedSample_HQ_transcript/65213 | Coverage 0.978 too low. | 4ce53f7ff2f115efc50d8afa76e1243b | 570 | Pfam | PF00035 | Double-stranded RNA binding motif | 50 | 113 | 3.1E-11 | T | 22-09-2020 | IPR014720 | Double-stranded RNA-binding domain |
| UnnamedSample_HQ_transcript/65213|m.17065 | UnnamedSample_HQ_transcript/65213 | Coverage 0.978 too low. | 4ce53f7ff2f115efc50d8afa76e1243b | 570 | Pfam | PF00035 | Double-stranded RNA binding motif | 284 | 348 | 1.5E-8 | T | 22-09-2020 | IPR014720 | Double-stranded RNA-binding domain |
| UnnamedSample_HQ_transcript/65213|m.17065 | UnnamedSample_HQ_transcript/65213 | Coverage 0.978 too low. | 4ce53f7ff2f115efc50d8afa76e1243b | 570 | Pfam | PF00035 | Double-stranded RNA binding motif | 402 | 464 | 1.1E-10 | T | 22-09-2020 | IPR014720 | Double-stranded RNA-binding domain |
| UnnamedSample_HQ_transcript/12693|m.4726 | UnnamedSample_HQ_transcript/12693 | Coverage 0.095 too low. | 79c6e9f5267111b9618daecd28a5ecef | 1097 | Pfam | PF06367 | Diaphanous FH3 Domain | 315 | 514 | 5.9E-43 | T | 22-09-2020 | IPR010472 | Formin, FH3 domain |
| UnnamedSample_HQ_transcript/12693|m.4726 | UnnamedSample_HQ_transcript/12693 | Coverage 0.095 too low. | 79c6e9f5267111b9618daecd28a5ecef | 1097 | Pfam | PF06371 | Diaphanous GTPase-binding Domain | 253 | 312 | 1.7E-14 | T | 22-09-2020 | IPR010473 | Formin, GTPase-binding domain |
| UnnamedSample_HQ_transcript/12693|m.4726 | UnnamedSample_HQ_transcript/12693 | Coverage 0.095 too low. | 79c6e9f5267111b9618daecd28a5ecef | 1097 | Pfam | PF06371 | Diaphanous GTPase-binding Domain | 55 | 174 | 2.5E-14 | T | 22-09-2020 | IPR010473 | Formin, GTPase-binding domain |
| UnnamedSample_HQ_transcript/12693|m.4726 | UnnamedSample_HQ_transcript/12693 | Coverage 0.095 too low. | 79c6e9f5267111b9618daecd28a5ecef | 1097 | Pfam | PF02181 | Formin Homology 2 Domain | 608 | 987 | 1.7E-94 | T | 22-09-2020 | IPR015425 | Formin, FH2 domain |
| UnnamedSample_HQ_transcript/70899|m.18089 | UnnamedSample_HQ_transcript/70899 | Coverage 0.955 too low. | 97e6f95dab929c960cdddaf7c4af06e8 | 476 | Pfam | PF00651 | BTB/POZ domain | 345 | 421 | 1.6E-15 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/70899|m.18089 | UnnamedSample_HQ_transcript/70899 | Coverage 0.955 too low. | 97e6f95dab929c960cdddaf7c4af06e8 | 476 | Pfam | PF13540 | Regulator of chromosome condensation (RCC1) repeat | 205 | 234 | 2.4E-5 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/70899|m.18089 | UnnamedSample_HQ_transcript/70899 | Coverage 0.955 too low. | 97e6f95dab929c960cdddaf7c4af06e8 | 476 | Pfam | PF00415 | Regulator of chromosome condensation (RCC1) repeat | 87 | 136 | 9.4E-15 | T | 22-09-2020 | IPR000408 | Regulator of chromosome condensation, RCC1 |
| UnnamedSample_HQ_transcript/76484|m.19116 | UnnamedSample_HQ_transcript/76484 | Coverage 0.814 too low. | aa5fff5080452fd3831b2514d57a8ad0 | 429 | Pfam | PF00151 | Lipase | 121 | 332 | 5.8E-37 | T | 22-09-2020 | IPR013818 | Lipase/vitellogenin |
| UnnamedSample_HQ_transcript/64737|m.16987 | UnnamedSample_HQ_transcript/64737 | Coverage 0.895 too low. | d13fdba216188e56f9191ed35e628941 | 501 | Pfam | PF08174 | Cell division protein anillin | 101 | 243 | 1.1E-44 | T | 22-09-2020 | IPR012966 | Anillin homology domain |
| UnnamedSample_HQ_transcript/35953|m.10919 | UnnamedSample_HQ_transcript/35953 | Identity 0.940 too low. | 75d0ff847693bf517c3ac88a63a4770f | 363 | Pfam | PF06325 | Ribosomal protein L11 methyltransferase (PrmA) | 161 | 234 | 1.8E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/113514|m.24244 | UnnamedSample_HQ_transcript/113514 | Coverage 0.815 too low. | 762d74da69193cb45ddc3dd44d1e416e | 208 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 52 | 166 | 1.8E-8 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/21260|m.7219 | UnnamedSample_HQ_transcript/21260 | Coverage 0.987 too low. | ad2b6d04ac64dcc9f68beb671ba43ea8 | 681 | Pfam | PF18372 | Integrin beta epidermal growth factor like domain 1 | 363 | 387 | 2.7E-9 | T | 22-09-2020 | IPR040622 | Integrin beta, epidermal growth factor-like domain 1 |
| UnnamedSample_HQ_transcript/21260|m.7219 | UnnamedSample_HQ_transcript/21260 | Coverage 0.987 too low. | ad2b6d04ac64dcc9f68beb671ba43ea8 | 681 | Pfam | PF00362 | Integrin beta chain VWA domain | 26 | 269 | 2.9E-112 | T | 22-09-2020 | IPR002369 | Integrin beta subunit, VWA domain |
| UnnamedSample_HQ_transcript/21260|m.7219 | UnnamedSample_HQ_transcript/21260 | Coverage 0.987 too low. | ad2b6d04ac64dcc9f68beb671ba43ea8 | 681 | Pfam | PF07965 | Integrin beta tail domain | 531 | 608 | 1.5E-13 | T | 22-09-2020 | IPR012896 | Integrin beta subunit, tail |
| UnnamedSample_HQ_transcript/21260|m.7219 | UnnamedSample_HQ_transcript/21260 | Coverage 0.987 too low. | ad2b6d04ac64dcc9f68beb671ba43ea8 | 681 | Pfam | PF08725 | Integrin beta cytoplasmic domain | 635 | 678 | 1.0E-21 | T | 22-09-2020 | IPR014836 | Integrin beta subunit, cytoplasmic domain |
| UnnamedSample_HQ_transcript/4362|m.1941 | UnnamedSample_HQ_transcript/4362 | Coverage 0.054 too low. | 90eb8863d2b8f28c6876b7f0b17b882c | 1079 | Pfam | PF00400 | WD domain, G-beta repeat | 384 | 454 | 0.24 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/4362|m.1941 | UnnamedSample_HQ_transcript/4362 | Coverage 0.054 too low. | 90eb8863d2b8f28c6876b7f0b17b882c | 1079 | Pfam | PF08366 | LLGL2 | 280 | 373 | 5.2E-30 | T | 22-09-2020 | IPR013577 | Lethal giant larvae homologue 2 |
| UnnamedSample_HQ_transcript/15593|m.5582 | UnnamedSample_HQ_transcript/15593 | Identity 0.926 too low. | d80b0e3c2957aace7162c69f6d6d4df1 | 318 | Pfam | PF16086 | Domain of unknown function (DUF4816) | 123 | 160 | 2.3E-9 | T | 22-09-2020 | IPR032134 | Protein of unknown function DUF4816 |
| UnnamedSample_HQ_transcript/15593|m.5582 | UnnamedSample_HQ_transcript/15593 | Identity 0.926 too low. | d80b0e3c2957aace7162c69f6d6d4df1 | 318 | Pfam | PF16086 | Domain of unknown function (DUF4816) | 277 | 314 | 2.0E-9 | T | 22-09-2020 | IPR032134 | Protein of unknown function DUF4816 |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
